Prognostic effect of hENT1, dCK and HuR expression by morphological type in periampullary adenocarcinoma, including pancreatic cancer

Background: Putative biomarkers of gemcitabine response have been extensively studied in pancreatic cancer, but less so in other types of periampullary adenocarcinoma. The most studied biomarker is human equilibrative nucleoside transporter 1 (hENT1), and the activating enzyme deoxycytidine kinase (...

Descripción completa

Detalles Bibliográficos
Autores principales: Elebro, Jacob, Ben Dror, Liv, Heby, Margareta, Nodin, Björn, Jirström, Karin, Eberhard, Jakob
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2016
Materias:
ORIGINAL ARTICLE: Gastrointestinal cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4819809/
https://www.ncbi.nlm.nih.gov/pubmed/26362587
http://dx.doi.org/10.3109/0284186X.2015.1075663

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4819809/
https://www.ncbi.nlm.nih.gov/pubmed/26362587
http://dx.doi.org/10.3109/0284186X.2015.1075663

Ejemplares similares